Cargando…

Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea

There are several guidelines for the use of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) which are used in other countries. However, the implementation of such guidelines in each country should be modified according to the country's clinical and epidemiological situati...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620396/
https://www.ncbi.nlm.nih.gov/pubmed/29027392
http://dx.doi.org/10.3947/ic.2017.49.3.243
_version_ 1783267578818330624
collection PubMed
description There are several guidelines for the use of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) which are used in other countries. However, the implementation of such guidelines in each country should be modified according to the country's clinical and epidemiological situation. Therefore, The Korean Society for AIDS founded a committee in 2016 to develop guidelines for the use of PrEP for HIV that are optimal for Korea's clinical and epidemiological situation. These guidelines aim to provide comprehensive information for PrEP implementation in Korea. The recommendations contain important information for physicians working to prevent HIV infection in actual clinical fields. The committee will regularly review and revise the guidelines based on changes in PrEP administration and HIV prevention practices.
format Online
Article
Text
id pubmed-5620396
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-56203962017-10-02 Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea Infect Chemother Special Article There are several guidelines for the use of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) which are used in other countries. However, the implementation of such guidelines in each country should be modified according to the country's clinical and epidemiological situation. Therefore, The Korean Society for AIDS founded a committee in 2016 to develop guidelines for the use of PrEP for HIV that are optimal for Korea's clinical and epidemiological situation. These guidelines aim to provide comprehensive information for PrEP implementation in Korea. The recommendations contain important information for physicians working to prevent HIV infection in actual clinical fields. The committee will regularly review and revise the guidelines based on changes in PrEP administration and HIV prevention practices. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017-09 2017-09-20 /pmc/articles/PMC5620396/ /pubmed/29027392 http://dx.doi.org/10.3947/ic.2017.49.3.243 Text en Copyright © 2017 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Article
Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
title Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
title_full Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
title_fullStr Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
title_full_unstemmed Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
title_short Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
title_sort summary of guidelines for the use of pre-exposure prophylaxis for hiv in korea
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620396/
https://www.ncbi.nlm.nih.gov/pubmed/29027392
http://dx.doi.org/10.3947/ic.2017.49.3.243
work_keys_str_mv AT summaryofguidelinesfortheuseofpreexposureprophylaxisforhivinkorea